Company Filing History:
Years Active: 2024
Title: Mohamad Hamieh: Innovator in Cancer Immunotherapy
Introduction
Mohamad Hamieh is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of cancer immunotherapy. His innovative work focuses on enhancing the immune response toward cancers and pathogens through advanced technologies.
Latest Patents
Hamieh holds a patent for "Enhanced chimeric antigen receptors and uses thereof." This patent provides methods and compositions for improving immune responses, particularly in the context of cancer treatment. The disclosed subject matter relates to novel designs of chimeric antigen receptors (CARs) and engineered immunoresponsive cells that incorporate these CARs. The engineered cells are designed to be antigen-directed and exhibit extended persistence without compromising their functional capabilities. He has 1 patent to his name.
Career Highlights
Mohamad Hamieh is affiliated with the Memorial Sloan Kettering Cancer Center, a leading institution in cancer research and treatment. His work at this prestigious center allows him to collaborate with some of the brightest minds in the field, contributing to groundbreaking advancements in cancer therapies.
Collaborations
Some of his notable coworkers include Michel Sadelain and Judith Feucht, who are also recognized for their contributions to cancer research and immunotherapy.
Conclusion
Mohamad Hamieh's innovative work in enhancing chimeric antigen receptors represents a significant advancement in cancer treatment. His contributions continue to shape the future of immunotherapy, offering hope for improved patient outcomes.